
BioAffinity Technologies Receives China Patent for Its Noninvasive Lung Cancer Diagnostic Tool
BioAffinity Technologies Receives China Patent for Its Noninvasive Lung Cancer Diagnostic Tool A biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung, the Company’s commercially available test for early-stage lung cancer,…












